What will healthcare look like in 2021? How will the upcoming election impact patient care in your community? Tune in to find out how policy changes and new legislation will shape—or disrupt—care delivery on a local and national level.

No CE will be awarded for this webinar. 

10/30/20 (NO CE) 

Overview: Find out how policy changes and new legislation will shape care delivery on both a local and national level.   


8/21/20 Moderator 

Elizabeth Plimack, MD, MS Ian Okazaki, MD  

Chief, Division of Genitourinary Medical Oncology HSCO Board Member  

Professor, Department of Hematology/Oncology Straub Clinic and Hospital  

Fox Chase Cancer Center, Temple University  



Carey Anders, MD  Medical Oncologist  Duke Cancer Center 



Julie Vose, MD, MBA  Professor, Internal Medicine  Division of Oncology & Hematology  University of Nebraska Medical Center, College of Medicine  


William Harris, MD  Associate Professor, Division of Oncology  University of Washington School of Medicine; Seattle Cancer Care Alliance 


Allison M. Hirschorn  Senior Coding and Reimbursement Specialist, Clinical Affairs  American Society of Clinical Oncology  

10/30/20 (No CE) 

Teri Bedard, RT(R)(T), CPC Executive Director, Client and Corporate Resources Revenue Cycle Coding Strategies 

Christian Downs, JD, MHA Executive Director, Association of Community Cancer Centers 

  Blake Oshiro Executive Vice President, Public Policy Capitol Consultants of Hawaii  


Accreditation Statement 



In support of improving patient care, these activities have been planned and implemented by AXIS Medical Education and Hawaii Society of Clinical Oncology (HSCO) AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 


>span class="TextRun SCXW182717822 BCX0" xml:lang="EN-US" lang="EN-US" data-redactor-span="true">ese activities were planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit each for learning and change. 


Credit Designation for Physicians 

AXIS Medical Education designates these live activities for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ each. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 


Credit Designation for Nursing 

AXIS Medical Education designates these continuing nursing education activities for 1.0 contact hour each. 

Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity. 


AXIS Contact Information  

For information about the accreditation of this program please contact AXIS at info@axismeded.org. 


Disclosure of Conflicts of Interest  

AXIS Medical Education requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by AXIS for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.  


The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity: 


Name of Faculty or Presenter/Planner 

Reported Financial Relationship 

Ian Okazaki, MD 

Nothing to disclose 

Elizabeth Plimack, MD, MS  


Received research grant from:Astellas, BMS, Genentech, Merck. 

Scientific advisory: AstraZeneca, Infinity Pharma, Genentech, Merck,  Pfizer, and  Seattle Genetics. 

Carey Anders, MD 

AbbvieEpizyme, Legend Pharmaceuticals, Vaniam Group, Janssen/Pharmacyclics, Kite Pharma, Acerta/Astra-ZenecaVerastemMiltenyl Biotec Inc, Loxo Oncology, AllogeneWugene, Celgene 

Research Funding:  

PUMA, Lilly, Merck, Seattle Genetics, NektarTesaro, G1-Therapeutics 


Genentech, Eisai, IPSEN, Seattle Genetics, Astra Zeneca, Novartis 


UptoDate and Jones & Bartlett 


Julie Vose, MD, MBA 

Advisor AbbvieEpizyme, Legend Pharmaceuticals, Vaniam Group, Janssen/Pharmacyclics, Kite Pharma, Acerta/Astra-ZenecaVerastemMiltenyl Biotec Inc, Loxo Oncology, AllogeneWugene, Celgene 

Research Grant: Acerta/Astra-Zeneca, Celgene, Incyte Corp, Kite Pharma, Novartis, Seattle Genetics, Inc.  

William Harris, MD 

Advisor: Eisai, Zymeworks 

Contracted Research: Agios, BMS, BTG, Basilea, Bayer, ExelixisMedimmune, Merck 

Allison M. Hirschorn 

Nothing to disclose 





The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:   

Name of Planner/Manager/Reviewer 

Reported Financial Relationship 

Michael Carney, MD 

Nothing to disclose 

Charles Miller, MD 

Nothing to disclose 

Ryon Nakasome, MD 

Nothing to disclose 

Christy Levine 

Nothing to disclose 

Marilyn Haas, PhD, RN, CNS, ANP-BC 

Nothing to disclose 

Dee Morgillo, MEd.,MT (ASCP), CHCP 

Nothing to disclose 




Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 


Disclosure of Unlabeled Use  This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planner of this activity do not recommend the use of any agent outside of the labeled indications.  The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the view of the planners. Please refer to the original prescribing information for each product for discussion of approved indications, contradictions and warnings. 

Method of Participation and Request for Credit  Attend/participate in the educational activity and review all course materials.  

- Complete the CE Declaration form online by b 11:59 PM ET within 14 days of the conclusion of each activity.  Instructions will be provided.    - Upon successful completion of the online form, your statement of completion will be presented to you to print.  



Teri Bedard, BA, RT(R)(T), CPC

Director, Client Services, Revenue Cycle Coding Strategies

Teri Bedard is the Executive Director, Client & Corporate Resources with Revenue Cycle Coding Strategies, LLC.  Her expertise includes over 20 years of medical experience.  Teri has served as a senior and Staff Radiation Therapist at renowned oncology practices across the Midwest and during her tenure with RCCS, has served as a Senior Consultant, Remote Solutions Manager, and Director, Client Services.   As a member of the RCCS team Teri advises and leads clients in the areas of billing and reimbursement for technology, monitoring government regulatory information and seeking new business opportunities.    

Teri completed her Bachelors of Arts degree at the University of Northern Iowa.  She completed her Radiologic Technology certificate at Mayo School for Health Related Sciences in Rochester, MN and her certificate for Radiation Therapy at Fairview University Medical Center in Minneapolis, MN.  She also earned her certification as a Certified Professional Coder (CPC) through the American Academy of Professional Coders (AAPC). 

Teri is active in the ARRT, ASRT, and AAPC.  She lectures and participates at national seminars in conjunction with the AAPC, ACCC, ACRO, and ASRT.  

Christian G. Downs, JD, MHA

Executive Director, Association of Community Cancer Centers

Christian G. Downs, JD, MHA, is Executive Director of the Association of Community Cancer Centers. Mr. Downs brings more than 15 years of association management expertise, guiding associations in their work on national policy and educational programming. He has been instrumental in working with healthcare providers, the Centers for Medicare & Medicaid Services (CMS), and Congress on association–specific issues.

Mr. Downs led the Association of Community Cancer Centers' efforts on such critical issues as easing implementation of new regulations, ensuring patient access to new cancer therapies, and refining physician office payments for delivery of services.

Mr. Downs worked in the public policy department of the American Society of Clinical Oncology (ASCO) on physician office and billing and coding issues. Previously he administered a large tertiary care hospital, managed a physician multispecialty practice, and worked for the Education and Health Committee of the Virginia State Senate.

Mr. Downs received his master's degree in health administration from the Medical College of Virginia and his law degree from George Mason University with a special focus on regulatory and administrative law. He is a board member of the Patient Advocate Foundation and C–Change, a large coordinating organization for cancer groups.

Blake Oshiro

Executive Vice President, Capital Consultants of Hawaii

Blake Oshiro served in the House of Representatives for eleven years where he was Majority Floor Leader for four years and Majority Leader for another four, serving in a leadership capacity almost from the beginning of his tenure. He also chaired or otherwise led committees relating to the environment, land use, labor, and criminal and constitutional law.

He understands the Hawaii legislative process as well, or better, than any person alive. From 2011 until 2014, he served as the Governor’s Deputy Chief of Staff with a specific oversight brief of all matters pertaining to policy and the state executive budget. He was the Governors’s lead person in dealing with the state legislature, the county governments and the Hawaii Congressional delegation.

A graduate of the William S. Richardson, School of Law, University of Hawaii, and the Kennedy School of Executive Education at Harvard University, he is an accomplished attorney of note, and the recipient of many professional awards for excellence, brilliance, and leadership on such issues as public interest, environmental, administrative, and constitutional law.

Michael Carney, MD (Moderator)

Obstetrician/Gynecologist, University of Hawaii Cancer Center

Michael Carney, MD, is an obstetrician/gynecologist in Honolulu, Hawaii. He is affiliated with Kapiolani Medical Center for Women & Children, The Queen’s Medical Center, and Maui Memorial Medical Center. Dr. Carney has extensive experience treating women for ovarian, cervical, and gynecological cancers. Prior to joining the Women’s Cancer Center and the John A. Burns School of Medicine, he worked at the prestigious Huntsman Cancer Institute. Dr. Carney completed both his obstetrics and gynecology residency and fellowship in gynecologic oncology at the Duke University Medical Center. He has developed clinical trials and is currently studying the molecular genetics of gynecological cancer to better understand and treat the disease.



The Hawaii Society of Clinical Oncology (HSCO) is a Chapter Member of the Association of Community Cancer Centers (ACCC). HSCO members receive access to valuable educational content and targeted resources through ACCC to support their professional development.

· Share your feedback in this brief Needs Assessment Survey and help us tailor our educational initiatives to meet your needs for the upcoming year and beyond.

· The ACCC COVID-19 Resource Center contains webcasts, podcasts, and blogs, and resources on the pandemic from federal and professional organizations.

· The ACCC COVID-19 Financial Advocacy Resources Hub features new and updated foundation assistance, updates to manufacturer assistance programs, and Medicare and Medicaid coverage updates.

· HSCO members can connect in real-time through members-only virtual discussion forum on ACCCeXchange. Within this forum, HSCO members from every profession involved in cancer care delivery ask and answer questions, discuss common challenges, and share knowledge and experience.  Join the discussion and connect with your peers.

·  Tap into the value of HSCO membership! Visit our membership page for more information on how you can join our community of professionals. If you’re unsure of your membership status, please contact our membership department today.

· The ACCCeLearning portal makes it easy to find education relevant to your needs and interests. Accessible on any device and at any time, courses are available in a variety of formats, so you can listen, watch, read or interact in ways that best suit your needs. Health professionals can claim CME/CPE/CNE credit for all applicable activities. Since you’re already logged in, take a look around today!

· Project ECHO: Bone Health in Patients with Breast and Prostate Cancers – Through a partnership with the American Cancer Society and Project ECHO, ACCC is offering case-based didactic presentations by experts to improve content knowledge and share evidence-based best practices.

· The ACCC Metastatic Breast Cancer Project features an online resource bank that connects you to curated materials to help close communication, education, and information gaps for patients and providers. 



Webinar 6: HSCO Clinical Education Series
10/30/2020 at 2:00 PM (EDT)   |  60 minutes
10/30/2020 at 2:00 PM (EDT)   |  60 minutes
Federal and State Policy Updates Feedback Survey
8 Questions
8 Questions Please provide your feedback on the sessions.

Already registered?
Log in to access.

Log In